特发性呼吸窘迫综合征新生儿表面活性剂治疗期间的经皮氧分压和二氧化碳分压
Transcutaneous PO2 and PCO2 during surfactant therapy in newborn infants with idiopathic respiratory distress syndrome.
作者信息
Oetomo S B, Robertson B, Okken A
机构信息
Dept. Paediatrics, University Hospital, Groningen, The Netherlands.
出版信息
Adv Exp Med Biol. 1987;220:121-2. doi: 10.1007/978-1-4613-1927-6_22.
PMID:3673752
Abstract
We conclude that surfactant treatment in newborn infants with IRDS results in decrease in TcPO2 and an increase in TcPO2 within minutes. The surfactant treatment procedure used in this study was not associated with hypoxemia. During surfactant treatment monitoring of TcPO2 and TcPCO2 is absolutely necessary.
摘要
我们得出结论，对患有IRDS的新生儿进行表面活性剂治疗会导致TcPO2在数分钟内下降，随后又升高。本研究中使用的表面活性剂治疗程序与低氧血症无关。在表面活性剂治疗期间，绝对有必要监测TcPO2和TcPCO2。
Zotero 插件